Global Point of Care (POC) Infectious Disease Diagnostic Testing Market Report 2018: Focus on Influenza, STD, HIV, Hepatitis, Malaria, C. difficile, E. coli, H. pylori & Home Test/OTC

    NEXT STORY
    BeyondSpring Presents Lead Asset’s Mechanism Data for Prevention of Chemotherapy-Induced Neutropenia
    PREV STORY
    Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Bioxytran’s MDX Viewer in conjunction with BXT-25 Will Validate Brain Metabolic Score as a Functional Endpoint in Ischemic Stroke

    author_avatar
    NASDAQ Market News

    Teneobio Enters a Research Collaboration and Licensing Agreement to Develop Next Generation Engineered Cell Therapies with Intellia Therapeutics

    author_avatar
    NASDAQ Market News

    At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth

    Full pipeline of late stage assets with blockbuster potential Positioned to deliver sales growth ...

    author_avatar
    NASDAQ Market News